- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
NVAX is climbing out of the hole
Posted on 7/8/22 at 5:04 pm
Posted on 7/8/22 at 5:04 pm
Bought some in the $80s and have been bag holding. Approvals here and around the world keep rolling in.
The Novavax vaccine is not mRNA. Nothing enters our cells an triggers our immune system to attack our own cells. It is simply an injection of covid spike proteins grown elsewhere on moth cells and harvested. This should be far less prone to side effects.
Posted on 7/8/22 at 5:33 pm to Auburn1968
Covid is fake
This post was edited on 7/8/22 at 5:33 pm
Posted on 7/8/22 at 5:45 pm to el Gaucho
You cant make a vaccine for a mutating RNA respiratory virus, clown world.
This post was edited on 7/8/22 at 5:45 pm
Posted on 7/11/22 at 9:50 am to Auburn1968
================
Novavax (NASDAQ:NVAX) announced an agreement with the U.S. government on Monday under which the Maryland-based biotech will initially supply 3.2M doses of its COVID-19 vaccine subject to its FDA authorization and CDC clearance.
The agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, will add the first protein-based COVID-19 shot for the country’s immunization drive.
"We are pleased to come one step closer to potentially offering our vaccine to physicians, healthcare organizations, and consumers who have been awaiting a protein-based vaccine option," Chief Executive Stanley C. Erck noted.
Last month, an advisory committee of the federal agency voted to recommend the emergency authorization for the NVX-CoV2373 vaccine for the prevention of COVID-19 in those aged 18 years and older.
https://seekingalpha.com/news/3855636-nvax-stock-on-watch-as-us-secures-32m-doses-of-covid-19-vaccine
Novavax (NASDAQ:NVAX) announced an agreement with the U.S. government on Monday under which the Maryland-based biotech will initially supply 3.2M doses of its COVID-19 vaccine subject to its FDA authorization and CDC clearance.
The agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, will add the first protein-based COVID-19 shot for the country’s immunization drive.
"We are pleased to come one step closer to potentially offering our vaccine to physicians, healthcare organizations, and consumers who have been awaiting a protein-based vaccine option," Chief Executive Stanley C. Erck noted.
Last month, an advisory committee of the federal agency voted to recommend the emergency authorization for the NVX-CoV2373 vaccine for the prevention of COVID-19 in those aged 18 years and older.
https://seekingalpha.com/news/3855636-nvax-stock-on-watch-as-us-secures-32m-doses-of-covid-19-vaccine
Posted on 7/19/22 at 8:54 am to Auburn1968
I'm a bag holder...
===============
Novavax signs production deal with SK bioscience for Omicron vaccine
South Korean vaccine maker SK bioscience announced on Tuesday that the company extended its partnership with Novavax (NASDAQ:NVAX) to manufacture and supply the U.S. biotech’s Omicron-adapted COVID-19 shot.
SK bioscience currently produces Novavax’s (NVAX) protein-based COVID shot targeted at the original variant.
LINK
===============
Novavax signs production deal with SK bioscience for Omicron vaccine
South Korean vaccine maker SK bioscience announced on Tuesday that the company extended its partnership with Novavax (NASDAQ:NVAX) to manufacture and supply the U.S. biotech’s Omicron-adapted COVID-19 shot.
SK bioscience currently produces Novavax’s (NVAX) protein-based COVID shot targeted at the original variant.
LINK
Popular
Back to top
3






